The Oncology Institute Inc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.14 | 37.13 | -100.38% | 7.64 | -101.83% |
| P/S |
|
0.000992 | 28.06 | -100% |
|
|
| P/BV |
|
0.11 | -2038.83 | -100.01% |
|
|
| P/FCF |
|
-0.3 | 265.35 | -100.11% |
|
|
| Ev/Ebitda |
|
-1.45 | -870.14 | -99.83% |
|
|
| Ev/S |
|
0.19 | 16.27 | -98.85% |
|
|
| Ev/FCF |
|
-2.44 | -715.09 | -99.66% |
|
|
| E/P |
|
-7.15 | -0.0039 | 183233.33% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-12.93 | 11.27 | -214.79% | -16.57 | -21.96% |
| ROE |
|
-213.36 | 385.88 | -155.29% |
|
|
| ROA |
|
-33.86 | -51.45 | -34.19% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-16.44 | 9.89 | -266.31% |
|
|
| ROCE |
|
-1592.84 | 5.27 | -30353.37% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-2.42 | 0.12 | -2038.46% | -2.12 | +13.99% |
| Nеt Debt/Ebitda |
|
-1.44 | -0.83 | 73.31% |
|
|
| Debt/Ratio |
|
0.71 | 0.0799 | 792.39% |
|
|
| Debt/Equity |
|
47.12 | -1.66 | -2945.94% |
|
|
| Debt/Net Income |
|
-1.9 | 0.17 | -1225.99% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0 | 0% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0 | 0% | ||
| DSI |
|
0 | 0 | 0% |
|
|
| Average dividend growth |
|
0 | 0 | 0% |
|
|
| Average percentage for 5 years |
|
0 | 0 | 0% |
|
|
| Average percentage for payments |
|
103.86 | 0 | 0% |
|
|
| Difference from average difference in sector |
|
0 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
109.8 | 294.53 | -62.72% | ||
| Growth impulse Ebitda in 5 years |
|
376.83 | 484.36 | -22.2% | ||
| Growth impulse Net Income in 5 years |
|
351.52 | 272.24 | 29.12% | ||
| Growth impulse FCF in 5 years |
|
4321.61 | -63.92 | -6860.97% | ||
| Growth impulse EPS in 5 years |
|
255.7 | -235.49 | -208.58% |
IP Score
5.09/10
